The impact of the menstrual cycle and ondansetron on postoperative nausea and vomiting

International Journal of Clinical Pharmacology Research

Volumn 18, Issue 4, 1998, Pages 153-158

  Bacic A ^a   Rumboldt, Z ^a,b   Gluncic I ^a   Buklijas J ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ONDANSETRON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NAUSEA; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; VOMITING;

ADOLESCENT; ADULT; ANTIEMETICS; FEMALE; HUMANS; MENSTRUAL CYCLE; NAUSEA; ONDANSETRON; POSTOPERATIVE COMPLICATIONS; VOMITING;

EID: 0032459152     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Watcha M.F., White P.F. Postoperative nausea and vomiting: its etiology, treatment and prevention. Anesthesiology, 77, 162, 1992.
2. Mitchelson F. Pharmacological agents affecting emesis: a review. Drugs, 43, 443, 1992.
3. Honkavaara P., Lehtinen A.M., Hovorka J. Nausea and vomiting after gynaecological laparoscopy depends upon the phase of the menstrual cycle. Can. J. Anaesth., 38, 876, 1991.
4. 3 receptors: pharmacologic and therapeutic aspects. J. Clin. Pharmacol., 35, 845, 1995.
5. Markham A., Sorkin E.M. Ondansetron: an update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs, 45, 931, 1993.
6. Wilde M.I., Markham A. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications. Drugs, 52, 773, 1996.
7. King M.J., Milazkiewicz R., Carli F., et al. Influence of neostigmine on postoperative vomiting. Brit. J. Anaesth., 61, 403, 1988.
8. Barnes N.M., Bunce K.T., Naylor R.J., Rudd J.A. The action of fentanyl to inhibit drug-induced emesis. Neuropharmacology, 30, 1073, 1991.
9. Andrews P.R.L., Whitehead S.A. Pregnancy sickness. News Physiol. Sci., 5, 5, 1990.
10. McKenyie R., Kovac A., O'Conor T., et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecological surgery. Anesthesiology, 78, 21, 1993.
11. Benedict C.R., Arbogast R., Martin L., et al. Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J. Cardiovasc. Pharmacol, 28, 53, 1996.